Skip to main content

Cefditoren Pregnancy and Breastfeeding Warnings

Brand names: Spectracef

Cefditoren Pregnancy Warnings

Cefditoren pivoxil has been assigned to pregnancy category B by the FDA. High-dose animal studies have not revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Cefditoren pivoxil is only recommended for use during pregnancy when benefit outweighs risk.

See references

Cefditoren Breastfeeding Warnings

There are no data on the excretion of cefditoren into human milk. Cefditoren is excreted into the milk of rats. The manufacturer recommends caution when cefditoren pivoxil is given to nursing women. The American Academy of Pediatrics classifies other cephalosporins as compatible with breast-feeding.

See references

See also

References for pregnancy information

  1. (2001) "Product Information. Spectracef (cefditoren)." TAP Pharmaceuticals Inc

References for breastfeeding information

  1. Briggs GG, Freeman RK, Yaffe SJ.. (1998) "Drugs in Pregnancy and Lactation." Baltimore, MD: Williams & Wilkins
  2. (2001) "Product Information. Spectracef (cefditoren)." TAP Pharmaceuticals Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer